Headache LogoAHS Logo

Patient Education Page

Each issue Headache publishes a new Toolbox, a page dedicated to patient education on a specific topic. The following Toolboxes are available:

Aura with Headache

Behavioral and Other Nonpharmacologic Treatments for Headache

Episodic Acute Migraine Treatment

Menstrual Migraine

Migraine and Cardiovascular Disease

Onabotulinumtoxin A

Stimulators for the Treatment of Headache

Sumatriptan Iontophoretic Path for Migraine

Transcutaneous Supraorbital NeuroStimulation (tSNS)

Sex and Headache

OnabotulinumtoxinA for the Treatment of Chronic Migraine

Injection Procedure Record for OnabotulinumtoxinA (BOTOX®, Allergan, Inc., Irvine, CA, USA) Treatment

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Acute Migraine Treatment

Opiate and Opioid (“Narcotic”) Therapy for Acute Migraine Headache

Occipital Nerve Blocks

Injectable Sumatriptan: Now Needle-Based or Needle-Free

Menstrual Migraine

Preventive (Prophylactic) Therapy

Migraine Aura

Headache Prevention With Complementary and Alternative Medicine

Acute Migraine: Treating Early

Your Visit to the Doctor: Achieving a Satisfactory Result

Tool Box—Headache Web Sites

Migraine "Chronification": What You Can Do

Treating an Acute Attack of Migraine

Compound Medications for Acute Migraine Treatment

Patent Foramen Ovale (PFO) and Migraine

Triptans, SSRIs/SNRIs and Serotonin Syndrome

The Truth About Triggers

What is Migraine?

Migraine "Chronification"

Topiramate (Topamax) for Migraine Prevention

Oral Triptan Therapy

Headache Diary

Controlled Medication Agreement

Monitoring Patients' Response to Acute Migraine Treatment: A Headache Attack Report Form

Opioid Therapy for Migraine

Patient Information Regarding Subcutaneous* Self-Administration of Dihydroergotamine (DHE)

Patient Information Regarding Subcutaneous Self-Administration of Sumatriptan (Imitrex)

Chronic Migraine: Medication Overuse Headache

Headache Toolbox

Search the Site

Search

 

Site Adverts

INTRODUCING THE HEADACHE  iPAD APP! 

 Follow the journal <i>Headache</i> on Twitter